Andre F - Search Results

1

Bevacizumab: the phoenix of breast oncology?

Andre F, Deluche E, Bonnefoi H. Andre F, et al. Lancet Oncol. 2015 Jun;16(6):600-1. doi: 10.1016/S1470-2045(15)70201-9. Epub 2015 May 11. Lancet Oncol. 2015. PMID: 25975636 Free article. No abstract available.

2

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer.

Andre F, Khalil A, Slimane K, Massard C, Mathieu MC, Vignot S, Assi H, Delaloge S, Spielmann M. Andre F, et al. J Clin Oncol. 2005 May 1;23(13):2996-3000. doi: 10.1200/JCO.2005.08.046. J Clin Oncol. 2005. PMID: 15860855 Clinical Trial.

3

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.

André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S. André F, et al. Lancet Oncol. 2009 Apr;10(4):381-90. doi: 10.1016/S1470-2045(09)70024-5. Epub 2009 Feb 25. Lancet Oncol. 2009. PMID: 19249242

4

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.

Andre F, Berrada N, Desmedt C. Andre F, et al. Curr Opin Oncol. 2010 Nov;22(6):547-51. doi: 10.1097/CCO.0b013e32833fb384. Curr Opin Oncol. 2010. PMID: 20842030 Review.

5

Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumab.

Andre F, Campone M, O'Regan R, Manlius C, Massacesi C, Sahmoud T, Mukhopadhyay P, Soria JC, Naughton M, Hurvitz SA. Andre F, et al. J Clin Oncol. 2010 Dec 1;28(34):5110-5. doi: 10.1200/JCO.2009.27.8549. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975068 Clinical Trial.

6

What can be done for patients with NSCLC without druggable targets?

Besse B, Andre F, Soria JC. Besse B, et al. Among authors: andre f. Lancet Oncol. 2013 Mar;14(3):191-2. doi: 10.1016/S1470-2045(13)70018-4. Lancet Oncol. 2013. PMID: 23452354 No abstract available.

7

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, Senn HJ; Panel members. Goldhirsch A, et al. Ann Oncol. 2013 Sep;24(9):2206-23. doi: 10.1093/annonc/mdt303. Epub 2013 Aug 4. Ann Oncol. 2013. PMID: 23917950 Free PMC article.

8

New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer.

Vicier C, Dieci MV, Andre F. Vicier C, et al. Among authors: andre f. Curr Opin Oncol. 2013 Nov;25(6):587-93. doi: 10.1097/CCO.0000000000000014. Curr Opin Oncol. 2013. PMID: 24097108 Review.

9

Issues in clinical research for metastatic breast cancer.

Dogan S, Andre F, Arnedos M. Dogan S, et al. Among authors: andre f. Curr Opin Oncol. 2013 Nov;25(6):625-9. doi: 10.1097/CCO.0000000000000018. Curr Opin Oncol. 2013. PMID: 24097109 Review.

10

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki M, Lacroix L, Cohen P, Gentien D, Adélaide J, Dalenc F, Goncalves A, Levy C, Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H. André F, et al. Lancet Oncol. 2014 Mar;15(3):267-74. doi: 10.1016/S1470-2045(13)70611-9. Epub 2014 Feb 7. Lancet Oncol. 2014. PMID: 24508104 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,145 results

Search Page

Filters